Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$62.39 - $113.8 $156,973 - $286,320
2,516 New
2,516 $286,000
Q2 2022

Aug 12, 2022

BUY
$79.4 - $116.36 $1,985 - $2,909
25 Added 0.96%
2,633 $211,000
Q1 2022

May 11, 2022

SELL
$86.42 - $109.81 $604 - $768
-7 Reduced 0.27%
2,608 $274,000
Q4 2021

Feb 08, 2022

SELL
$98.56 - $119.91 $18,332 - $22,303
-186 Reduced 6.64%
2,615 $282,000
Q3 2021

Nov 10, 2021

SELL
$91.91 - $110.37 $551 - $662
-6 Reduced 0.21%
2,801 $307,000
Q2 2021

Aug 11, 2021

SELL
$86.24 - $95.92 $2,587 - $2,877
-30 Reduced 1.06%
2,807 $263,000
Q1 2021

May 11, 2021

BUY
$71.83 - $95.48 $203,781 - $270,876
2,837 New
2,837 $262,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Dorsey & Whitney Trust CO LLC Portfolio

Follow Dorsey & Whitney Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey & Whitney Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey & Whitney Trust CO LLC with notifications on news.